Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FAWLK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,645
Award facts
- Contract value 100% obligated
- $31,644.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,644.53 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 15, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. The delivery order, which has an ultimate completion date of September 16, 2025, represents a continuation under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. This delivery order does not utilize a set-aside designation. Zepbound (tirzepatide) is a GLP-1 receptor agonist medication used for weight management, and the fulfillment of this order supports DLA's pharmaceutical supply needs for military healthcare facilities nationwide.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, holding a robust portfolio of delivery orders under the DLA's SPE2DB program covering an extensive range of prescription medications, biologics, and medical consumables. The place of performance for this delivery order is Conshohocken, Pennsylvania. DMS Pharmaceutical Group's consistent success in securing federal pharmaceutical contracts underscores its capability to reliably deliver specialized medical products to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FAWLK?
SPE2DB25FAWLK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FAWLK worth?
The government has obligated $31,645 on SPE2DB25FAWLK.
Is contract SPE2DB25FAWLK an order under another contract?
Yes. SPE2DB25FAWLK is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWLK competed?
The extent of competition for SPE2DB25FAWLK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award